Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells

X Wang, CM Cahill, MA Piñeyro, J Zhou… - …, 1999 - academic.oup.com
X Wang, CM Cahill, MA Piñeyro, J Zhou, ME Doyle, JM Egan
Endocrinology, 1999academic.oup.com
Abstract Glucagon-like peptide-1 (GLP-1) enhances insulin biosynthesis and secretion as
well as transcription of the insulin, GLUT2 and glucokinase genes. The latter are also
regulated by the PDX-1 homeoprotein. We investigated the possibility that GLP-1 may be
having its long-term pleiotropic effects through a hitherto unknown regulation of PDX-1. We
found that PDX-1 mRNA level was significantly increased (p< 0.01) after 2 hours and insulin
mRNA level was subsequently increased (p< 0.01) after 3 hours of treatment with GLP-1 (10 …
Abstract
Glucagon-like peptide-1 (GLP-1) enhances insulin biosynthesis and secretion as well as transcription of the insulin, GLUT2 and glucokinase genes. The latter are also regulated by the PDX-1 homeoprotein. We investigated the possibility that GLP-1 may be having its long-term pleiotropic effects through a hitherto unknown regulation of PDX-1. We found that PDX-1 mRNA level was significantly increased (p<0.01) after 2 hours and insulin mRNA level was subsequently increased (p<0.01) after 3 hours of treatment with GLP-1 (10 nm) in RIN 1046-38 insulinoma cells. Under these experimental conditions, there was also a 1.6-fold increase in the expression of PDX-1 protein in whole cell and nuclear extracts. Overexpression of PDX-1 in these cells confirmed the finding of the wild type cells such that GLP-1 induced a 2-fold increase in whole cell extracts and a 3-fold increase in nuclear extracts of PDX-1 protein levels. The results of electrophoretic mobility shift experiments showed that PDX-1 protein binding to the A1 element of the rat insulin II promoter was also increased 2 h post treatment with GLP-1.
In summary, we have uncovered a previously unknown aspect to the regulation of PDX-1 in beta cells. This has important implications in the physiology of adult beta cells and the treatment of type 2 diabetes mellitus with GLP-1 or its analogs.
Oxford University Press